Botulinum toxin
Evidence-based neurology checklist on botulinum toxin: Types Abobotulinum toxin A Onabotulinum toxin A Daxibotulinum toxin A Incobotulinum toxin A Neubotulinum toxin A Rimabotulinum toxin B Movement disorder indications Other indications Off-label indications Adverse events Reasons for poor response
Types
- Abobotulinum toxin A
- Onabotulinum toxin A
- Daxibotulinum toxin A
- Incobotulinum toxin A
- Neubotulinum toxin A
- Rimabotulinum toxin B
Movement disorder indications
Other indications
Off-label indications
Adverse events
Reasons for poor response
References
- Simpson DM, Blitzer A, Brashear A, et al. Assessment: Botulinum neurotoxin for the treatment of movement disorders (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 2008; 70:1699-1706.
- Evidente VGH, Adler CH. An update on the neurologic applications of botulinum toxin. Curr Neurol Neurosci Rep 2010; 10:338-344.
- Thenganatt MA, Fahn S. Botulinum toxin for the treatment of movement disorders. Curr Neurol Neurosci Rep 2012; 12:399-409.
- Albanese A, Abbruzzese G, Dressler D, et al. Practical guidance for CD management involving treatment of botulinum toxin: a consensus statement. J Neurol 2015; 262:2201-2213.
- Marion MH, Humberstone M, Grunewald R, Wimalaratna S. British Neurotoxin Network recommendations for managing cervical dystonia in patients with a poor response to botulinum toxin. Pract Neurol 2016; 16:288-295.
- And 9 more. Subscribe to see the full list
